Navigation Links
Burg Simpson Files Yasmin/Yaz Lawsuits
Date:7/10/2009

CINCINNATI, July 10 /PRNewswire/ -- Attorneys at BURG SIMPSON ELDREDGE HERSH & JARDINE, P.C. filed four lawsuits this week in federal court against Bayer alleging that Bayer's oral contraceptives Yasmin and Yaz are defective and present an increased risk of injury to women. Three of the suits were filed in Ohio and the fourth in Wisconsin. The four women who filed suit suffered either deep vein thrombosis, pulmonary embolism, and/or stroke while taking these products. In addition, both Yasmin and Yaz have been associated with heart attacks and even death in young women.

The lawsuits allege that Bayer failed to warn the women and their physicians of the increased risk of injury, while over-promoting the benefits of the drugs. In October of 2008, the Food and Drug Administration (FDA) sent Bayer a warning letter objecting to its television ads claiming that Yaz has additional benefits compared to other oral contraceptives. The FDA's letter warned that Yaz actually has additional risks because it contains the progestin drospirenone. The warning prompted an agreement for Bayer to spend $20 million on corrective ads.

Burg Simpson shareholders Michael Burg, Janet Abaray and Seth Katz have vast amounts of experience in litigating dangerous birth control product cases. Mr. Burg and Ms. Abaray currently serve as co-lead counsel in the Ortho Evra Product Liability Litigation, MDL No. 1742. They are leading the firm's Yasmin and Yaz litigation and expect to file additional lawsuits in the coming weeks.

www.burgsimpson.com


'/>"/>
SOURCE Burg Simpson Eldredge Hersh & Jardine, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Ashlee Simpson to Read Holiday Stories to Children in Hospitals Throughout the Country Premiering Vapps Holiday Storybook Event
2. ev3 Inc. Accepts Resignation of Dr. John Simpson
3. Jessica Simpson Lends Healthy Image for Drink Smart Campaign
4. Alvarado Hospital Files Countersuit Against Blue Shield
5. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
6. Pharsight Files Application for Nasdaq Capital Market Listing
7. Gentiva(R) Health Services Files Universal Shelf Registration Statement
8. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
9. CIGNA Behavioral Health Offers Members Online Provider Profiles
10. American Media Operations, Inc. Files Form 10-Q For First Quarter 2007
11. RxElite Files Registration Statement with Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Georgia (PRWEB) , ... March 28, 2017 , ... ... to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, property ... a leader in the real estate valuation industry for more than 40 years. ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: